RecruitingPhase 4NCT07172893

A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL

A Non-Randomized Open Label Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of DermaBind TL, a Placental Membrane Allograft Intended for Use in the Management of Non-Healing Ulcers

Sponsor

HealthTech Wound Care

Enrollment

150 participants

Start Date

Dec 10, 2025

Study Type

INTERVENTIONAL

Conditions

Diabetic Foot Ulcer (DFU)Venous Leg Ulcer (VLU)

Summary

The purpose of this clinical evaluation is to collect patient outcome data and evaluate the efficacy, safety and tolerability of HealthTech DermaBind TL™ in patients with chronic non-healing wounds in patients with chronic non-healing ulcers.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called DermaBind TL for people with diabetic foot ulcer (dfu) and venous leg ulcer (vlu). The study is currently recruiting participants at 10 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALDermaBind TL

Full-Thickness Dehydrated Placental Allograft

Locations(10)

Midland Florida Clinical Research Center

DeLand, Florida, United States

Pharmakon Medical Research

Palm Beach Gardens, Florida, United States

Vital Medical Research

Sweetwater, Florida, United States

EMbassy Research Network

Bloomfield Township, Michigan, United States

US Foot and Ankle Specialists-Cary Satellite Site

Cary, North Carolina, United States

US Foot and Ankle Specialists

Raleigh, North Carolina, United States

US Foot and Ankle Specialists

Blue Ash, Ohio, United States

Lower Extremity Institute for Research and Therapy

Boardman, Ohio, United States

Perfizien Clinical Research, LLC.

Houston, Texas, United States

Foot and Ankle Specialists of the Mid-Atlantic

Salem, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07172893

Related Trials

CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs

NCT077015907 locations

ConvaVAC™ Ag+ Negative Pressure Wound Therapy System in Chronic Wounds

NCT073420497 locations

Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy

NCT070864431 location

PAW-Hydrogel for Chronic Wound Healing

NCT075411961 location

Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue

NCT074982181 location